Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: Possible beneficial effect of vitamin therapy

Y. S. Hong; S. H. Korman; J. Lee; Pushpankur Ghoshal; Q. Wu; V. Barash; S. Kang; S. Oh; M. Kwon; A. Gutman; A. Rachmel; M. S. Patel

doi:10.1023/B:BOLI.0000010004.12053.5b

Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: Possible beneficial effect of vitamin therapy

Y. S. Hong, S. H. Korman, J. Lee, Pushpankur Ghoshal, Q. Wu, V. Barash, S. Kang, S. Oh, M. Kwon, A. Gutman, A. Rachmel, M. S. Patel

Research output: Contribution to journal › Short survey › peer-review

24 Scopus citations

Abstract

Dihydrolipoamide dehydrogenase (E3) deficiency with a clinical phenotype and genotype (Gly194Cys homozygous), previously identified only in Ashkenazi Jewish patients, was diagnosed in two Palestinian Arab siblings and two unrelated Ashkenazi Jewish patients. While three of the four patients died in childhood without specific treatment, the surviving patient at age 18 years may have benefited from long-term daily supplementation with a cocktail of riboflavin, biotin, coenzyme Q and carnitine.

Original language	English (US)
Pages (from-to)	816-818
Number of pages	3
Journal	Journal of Inherited Metabolic Disease
Volume	26
Issue number	8
DOIs	https://doi.org/10.1023/B:BOLI.0000010004.12053.5b
State	Published - 2003
Externally published	Yes

ASJC Scopus subject areas

Genetics
Genetics(clinical)

Access to Document

10.1023/B:BOLI.0000010004.12053.5b

Fingerprint Dive into the research topics of 'Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: Possible beneficial effect of vitamin therapy'. Together they form a unique fingerprint.

Cite this

Hong, Y. S., Korman, S. H., Lee, J., Ghoshal, P., Wu, Q., Barash, V., Kang, S., Oh, S., Kwon, M., Gutman, A., Rachmel, A., & Patel, M. S. (2003). Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: Possible beneficial effect of vitamin therapy. Journal of Inherited Metabolic Disease, 26(8), 816-818. https://doi.org/10.1023/B:BOLI.0000010004.12053.5b

Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency : Possible beneficial effect of vitamin therapy. / Hong, Y. S.; Korman, S. H.; Lee, J.; Ghoshal, Pushpankur; Wu, Q.; Barash, V.; Kang, S.; Oh, S.; Kwon, M.; Gutman, A.; Rachmel, A.; Patel, M. S.

In: Journal of Inherited Metabolic Disease, Vol. 26, No. 8, 2003, p. 816-818.

Research output: Contribution to journal › Short survey › peer-review

Hong, YS, Korman, SH, Lee, J, Ghoshal, P, Wu, Q, Barash, V, Kang, S, Oh, S, Kwon, M, Gutman, A, Rachmel, A & Patel, MS 2003, 'Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: Possible beneficial effect of vitamin therapy', Journal of Inherited Metabolic Disease, vol. 26, no. 8, pp. 816-818. https://doi.org/10.1023/B:BOLI.0000010004.12053.5b

Hong, Y. S. ; Korman, S. H. ; Lee, J. ; Ghoshal, Pushpankur ; Wu, Q. ; Barash, V. ; Kang, S. ; Oh, S. ; Kwon, M. ; Gutman, A. ; Rachmel, A. ; Patel, M. S. / Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency : Possible beneficial effect of vitamin therapy. In: Journal of Inherited Metabolic Disease. 2003 ; Vol. 26, No. 8. pp. 816-818.

@article{c1e17826e4f34f2a8d395925aeebd801,

title = "Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: Possible beneficial effect of vitamin therapy",

abstract = "Dihydrolipoamide dehydrogenase (E3) deficiency with a clinical phenotype and genotype (Gly194Cys homozygous), previously identified only in Ashkenazi Jewish patients, was diagnosed in two Palestinian Arab siblings and two unrelated Ashkenazi Jewish patients. While three of the four patients died in childhood without specific treatment, the surviving patient at age 18 years may have benefited from long-term daily supplementation with a cocktail of riboflavin, biotin, coenzyme Q and carnitine.",

author = "Hong, {Y. S.} and Korman, {S. H.} and J. Lee and Pushpankur Ghoshal and Q. Wu and V. Barash and S. Kang and S. Oh and M. Kwon and A. Gutman and A. Rachmel and Patel, {M. S.}",

year = "2003",

doi = "10.1023/B:BOLI.0000010004.12053.5b",

language = "English (US)",

volume = "26",

pages = "816--818",

journal = "Journal of Inherited Metabolic Disease",

issn = "0141-8955",

publisher = "Springer Netherlands",

number = "8",

}

TY - JOUR

T1 - Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency

T2 - Possible beneficial effect of vitamin therapy

AU - Hong, Y. S.

AU - Korman, S. H.

AU - Lee, J.

AU - Ghoshal, Pushpankur

AU - Wu, Q.

AU - Barash, V.

AU - Kang, S.

AU - Oh, S.

AU - Kwon, M.

AU - Gutman, A.

AU - Rachmel, A.

AU - Patel, M. S.

PY - 2003

Y1 - 2003

N2 - Dihydrolipoamide dehydrogenase (E3) deficiency with a clinical phenotype and genotype (Gly194Cys homozygous), previously identified only in Ashkenazi Jewish patients, was diagnosed in two Palestinian Arab siblings and two unrelated Ashkenazi Jewish patients. While three of the four patients died in childhood without specific treatment, the surviving patient at age 18 years may have benefited from long-term daily supplementation with a cocktail of riboflavin, biotin, coenzyme Q and carnitine.

AB - Dihydrolipoamide dehydrogenase (E3) deficiency with a clinical phenotype and genotype (Gly194Cys homozygous), previously identified only in Ashkenazi Jewish patients, was diagnosed in two Palestinian Arab siblings and two unrelated Ashkenazi Jewish patients. While three of the four patients died in childhood without specific treatment, the surviving patient at age 18 years may have benefited from long-term daily supplementation with a cocktail of riboflavin, biotin, coenzyme Q and carnitine.

UR - http://www.scopus.com/inward/record.url?scp=0942266379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0942266379&partnerID=8YFLogxK

U2 - 10.1023/B:BOLI.0000010004.12053.5b

DO - 10.1023/B:BOLI.0000010004.12053.5b

M3 - Short survey

C2 - 14765544

AN - SCOPUS:0942266379

VL - 26

SP - 816

EP - 818

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 8

ER -